Nothing Special   »   [go: up one dir, main page]

ATE348158T1 - Neuartiges collectin - Google Patents

Neuartiges collectin

Info

Publication number
ATE348158T1
ATE348158T1 AT99938607T AT99938607T ATE348158T1 AT E348158 T1 ATE348158 T1 AT E348158T1 AT 99938607 T AT99938607 T AT 99938607T AT 99938607 T AT99938607 T AT 99938607T AT E348158 T1 ATE348158 T1 AT E348158T1
Authority
AT
Austria
Prior art keywords
novel collectin
collectin
seq
sequence set
set out
Prior art date
Application number
AT99938607T
Other languages
English (en)
Inventor
Nobutaka Wakamiya
Original Assignee
Fuso Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Ind filed Critical Fuso Pharmaceutical Ind
Application granted granted Critical
Publication of ATE348158T1 publication Critical patent/ATE348158T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99938607T 1998-08-24 1999-08-24 Neuartiges collectin ATE348158T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23761198 1998-08-24

Publications (1)

Publication Number Publication Date
ATE348158T1 true ATE348158T1 (de) 2007-01-15

Family

ID=17017889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938607T ATE348158T1 (de) 1998-08-24 1999-08-24 Neuartiges collectin

Country Status (14)

Country Link
US (3) US20070020729A1 (de)
EP (1) EP1108786B1 (de)
JP (1) JP4441118B2 (de)
KR (1) KR100633221B1 (de)
CN (1) CN1320164A (de)
AT (1) ATE348158T1 (de)
AU (1) AU751173B2 (de)
CA (1) CA2340934C (de)
CY (1) CY1106041T1 (de)
DE (1) DE69934415T2 (de)
DK (1) DK1108786T3 (de)
ES (1) ES2279629T3 (de)
PT (1) PT1108786E (de)
WO (1) WO2000011161A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4685315B2 (ja) 2000-02-14 2011-05-18 扶桑薬品工業株式会社 新規スカベンジャーレセプター
WO2003035679A2 (en) 2001-10-25 2003-05-01 Medical Research Council Molecules
JP5592357B2 (ja) 2008-05-27 2014-09-17 ダコ・デンマーク・エー/エス 新規なハイブリダイゼーションバッファーを用いた染色体異常の検出のための組成物及び方法
ES2536198T3 (es) * 2008-12-22 2015-05-21 National University Corporation Hokkaido University Sustancia proteínica que tiene estructura de hélice triple y método de producción de la misma
US9388456B2 (en) 2009-02-26 2016-07-12 Dako Denmark A/S Compositions and methods for performing a stringent wash step in hybridization applications
GB2482277B (en) * 2009-05-21 2014-06-04 Polaris Solutions Ltd Camouflage device
US8609606B2 (en) 2010-03-04 2013-12-17 Fuso Pharmaceutical Industries, Ltd. Polypeptide acting to enhance ischemic diseases
WO2013046033A1 (en) 2011-09-30 2013-04-04 Dako Denmark A/S Hybridization compositions and methods using formamide
EP2768974B1 (de) 2011-10-21 2017-07-19 Dako Denmark A/S Hybridisierungszusammensetzungen und -verfahren
CN115925861B (zh) * 2022-10-13 2024-02-20 海南大学 驼背鲈C-型凝集素CaCTL4E基因、蛋白、载体、重组细胞及其应用
JP7590631B1 (ja) * 2023-03-23 2024-11-26 積水メディカル株式会社 肺サーファクタントプロテインdの測定方法、測定キット、モノクローナル抗体及び細胞

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK570485D0 (da) * 1985-12-10 1985-12-10 Novo Industri As Humant conglutinin
US5270199A (en) * 1987-08-20 1993-12-14 The Children's Medical Center Corporation Human mannose-binding protein
CA2400143C (en) * 1995-08-17 2009-05-12 Fuso Pharmaceutical Industries, Ltd. Recombinant conglutinin and producing method thereof
JPH09238683A (ja) * 1996-03-12 1997-09-16 Eijiin Kenkyusho:Kk ウェルナー症候群の原因遺伝子の存在する領域にある新規ws−3遺伝子及びその遺伝子がコードするタンパク質
WO1998055614A2 (en) * 1997-06-04 1998-12-10 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
EP1108786A1 (de) 2001-06-20
ES2279629T3 (es) 2007-08-16
CA2340934C (en) 2009-02-17
KR20010085583A (ko) 2001-09-07
DK1108786T3 (da) 2007-04-16
AU5305699A (en) 2000-03-14
US20130230918A1 (en) 2013-09-05
EP1108786A4 (de) 2003-08-06
WO2000011161A1 (fr) 2000-03-02
US20110065177A1 (en) 2011-03-17
US20070020729A1 (en) 2007-01-25
CY1106041T1 (el) 2011-04-06
DE69934415T2 (de) 2007-09-27
DE69934415D1 (de) 2007-01-25
JP4441118B2 (ja) 2010-03-31
EP1108786B1 (de) 2006-12-13
CN1320164A (zh) 2001-10-31
CA2340934A1 (en) 2000-03-02
PT1108786E (pt) 2007-02-28
AU751173B2 (en) 2002-08-08
KR100633221B1 (ko) 2006-10-11

Similar Documents

Publication Publication Date Title
DE60021497D1 (de) Menschliche, für zyklische Nukleotide spezifische Phosphodiesterase
RS50364B (sr) Modifikovani faktor viii
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
DE69636495D1 (de) Multi-tumor abweichende wachstumsgene
CY1106041T1 (el) Καινοφανης συλλεκτινη
EP0769968A4 (de) Retrovirale vektoren, die von gegen lyse durch menschliches serum resistenten produktionszellinien produziert werden
IT1283876B1 (it) Molecole chimeriche ribozima-snrna ad attivita' catalitica per rna a localizzazione nucleare
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO1995003406A3 (en) Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
NZ508439A (en) Novel endometriosis-associated gene
GB0020331D0 (en) Enzyme
ATE353913T1 (de) Neue collectine
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
EA199900893A1 (ru) Бактериальные плазмиды
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DE69534738D1 (de) Leukocyten-aktivierender Faktor
BR0107799A (pt) Proteìna de interação de wt1 wtip
YU29801A (sh) Gen prv-1 i njegova primena
DE60021707D1 (de) Beta-primeverosidase gen
ECSP982465A (es) Plasmidos bacterianos
WO2000029433A3 (en) 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1108786

Country of ref document: EP